Compile Data Set for Download or QSAR
Report error Found 101 of ic50 data for polymerid = 50006699
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50078630(CHEMBL4296718)
Affinity DataIC50: 136nMAssay Description:Inhibition of BAZ2A (unknown origin) after 30 mins by AlphaScreen assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148289(CHEMBL3770199)
Affinity DataIC50: 160nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526963(CHEMBL4456922)
Affinity DataIC50: 316nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148270(CHEMBL3739699)
Affinity DataIC50: 400nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148290(CHEMBL3770277)
Affinity DataIC50: 550nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148334(CHEMBL3770214)
Affinity DataIC50: 580nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148281(CHEMBL3770847)
Affinity DataIC50: 720nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM310898(US10150767, Example 22 | N,N-dimethyl-3-(6-methyl-...)
Affinity DataIC50: 880nMAssay Description:Binding affinity to human partial length BAZ2A expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM310898(US10150767, Example 22 | N,N-dimethyl-3-(6-methyl-...)
Affinity DataIC50: 880nMAssay Description:Binding affinity to human partial length BAZ2A expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148371(CHEMBL3770738)
Affinity DataIC50: 890nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148282(CHEMBL3771216)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148280(CHEMBL3771080)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148279(CHEMBL3769753)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148283(CHEMBL3770155)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148278(CHEMBL3769588)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50364107(CHEMBL1950956)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148284(CHEMBL3770449)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148276(CHEMBL3770112)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148277(CHEMBL3770410)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148275(CHEMBL3769769)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601335(CHEMBL5178939)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148287(CHEMBL3771370)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148288(CHEMBL3770493)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526958(CHEMBL4459169)
Affinity DataIC50: 6.31E+3nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148274(CHEMBL3769490)
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148273(CHEMBL3769417)
Affinity DataIC50: 8.60E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM342597(N-[3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindo...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50256397(CHEMBL4088466)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50158624(CHEMBL3786012)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601334(CHEMBL5172246)
Affinity DataIC50: 1.06E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601332(CHEMBL5174553)
Affinity DataIC50: 1.09E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601322(CHEMBL5192710)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601341(CHEMBL5205271)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601319(CHEMBL5186561)
Affinity DataIC50: 1.14E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601320(CHEMBL5170762)
Affinity DataIC50: 1.18E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601318(CHEMBL5172147)
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601331(CHEMBL5200427)
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601328(CHEMBL5205483)
Affinity DataIC50: 1.29E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601327(CHEMBL5171471)
Affinity DataIC50: 1.31E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601343(CHEMBL5190134)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601337(CHEMBL5190709)
Affinity DataIC50: 1.41E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601340(CHEMBL5191503)
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526959(CHEMBL4522991)
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526959(CHEMBL4522991)
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601323(CHEMBL5207551)
Affinity DataIC50: 2.92E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148272(CHEMBL3770550)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601339(CHEMBL5184671)
Affinity DataIC50: 3.13E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50028142(CHEMBL2177300)
Affinity DataIC50: 3.16E+4nMAssay Description:Inhibition of human BAZ2A by BROMOscan assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601290(CHEMBL5195335)
Affinity DataIC50: 3.32E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Human)
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601336(CHEMBL5179501)
Affinity DataIC50: 3.32E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: